A couple of interesting things today from RLFTF.
Post# of 148207
(Total Views: 613)
Posted On: 02/09/2021 10:44:14 AM
.jpg)
A couple of interesting things today from RLFTF.
From their press release--i think this is a nice way of saying it really doesn't work but we're going to ask the FDA for approval.
“With the improvement in survival since the start of the pandemic, differences in patient survival were not seen at day 28, and patients are now being followed through day 60. The study has not identified an overall difference in the stated primary endpoint of recovery from respiratory failure from summary data.”
Since this announcement this morning the stock price is down to S0.3801
RELIEF ANNOUNCES RESIGNATION OF THOMAZ BURCKHARDT AS MEMBER OF THE BOARD OF DIRECTORS
https://relieftherapeutics.com/newsblog/relie...-directors
I guess he resigned and sold all of his shares in the company and the people who slam/short CYDY are worried about a board members wife who may POTENTIALLY sell her shares???? WOW--let's guess what company I am investing more money in.
NJ
From their press release--i think this is a nice way of saying it really doesn't work but we're going to ask the FDA for approval.
“With the improvement in survival since the start of the pandemic, differences in patient survival were not seen at day 28, and patients are now being followed through day 60. The study has not identified an overall difference in the stated primary endpoint of recovery from respiratory failure from summary data.”
Since this announcement this morning the stock price is down to S0.3801
RELIEF ANNOUNCES RESIGNATION OF THOMAZ BURCKHARDT AS MEMBER OF THE BOARD OF DIRECTORS
https://relieftherapeutics.com/newsblog/relie...-directors
I guess he resigned and sold all of his shares in the company and the people who slam/short CYDY are worried about a board members wife who may POTENTIALLY sell her shares???? WOW--let's guess what company I am investing more money in.
NJ
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼